Therefore, the diminished hippocampal CX3CR1 level, which we observed in prenatally Poly I:C-treated young offspring, opens the possibility that disruptions of microglia-mediated activity could contribute to neurodevelopmental deficits manifested as behavioural schizophrenia-like changes in adulthood. The gene discussed is CX3CR1; the disease is schizophrenia.